42% reduction in autism symptoms in 20 sessions of HEG neurofeedback.
Hemoencephalography for Autistic
Spectrum DisorderRobert Coben, Ph.D. Private Practice; Director,
NeuroRehabilitation and Neuropsychological Services. Massapequa Park,
New York firstname.lastname@example.org Research & Clinical Application
The epidemiology of Autism is approximately 60 per 10,000 (1 in 166)
children (Medical Research Council, 2001). Assessment-guided
neurofeedback has been shown to significantly reduce the core symptoms
of Autism (Coben, 2005). Hemoencephalography is a form of neurofeedback
that has also been successfully utilized to improve function in patients
with a wide range of diagnoses including Autism (Toomim, 2004).
Thirty-five patients with Autism received 20 sessions of Near
Infrared or Passive Infrared Hemoencephalography (nir / pir HEG). The
wait list control group (n=12) was matched for gender, age, race,
handedness, IQ and other treatments. All patients had completed 20
sessions of EEG Biofeedback. The next phase of training was
assessment-guided HEG. All patients had identified frontal system
dysfunction based on neurobehavioral, neuropsychological testing,
infrared imaging, and QEEG data.
Findings indicated a success rate of 90%. A 42% reduction in symptoms
was reported. Social interaction deficits decreased by 55%.
Communication and social communication deficits decreased by 55% and
52%, respectively. There were statistically significant (p < .05)
improvements in neurobehavioral and neuropsychological functioning.
These improvements were associated with enhancement of thermal
regulation and reduction in abnormal QEEG findings. These findings
suggest that Autism can be successfully treated with assessment-guided
pir and nir HEG.